Abbie Celniker serves as Executive at Eleven Biotherapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Abbie Celniker has executed 4 insider transactions totaling $79.9K, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 28, 2016 involved selling 10,031 shares valued at $30.1K.
Abbie Celniker currently holds 409,915 shares of Eleven Biotherapeutics, Inc. (EBIO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Abbie Celniker has been a net seller of EBIO stock. They have purchased $0 and sold $79.9K worth of shares.
Abbie Celniker's most recent insider trade was on Sep 28, 2016, when they sold 10,031 shares at $3.00 per share.
Get notified when new Form 4 filings are submitted
| $2.08 |
| Discretionary |
| Dec 28, 2015 | EBIO | $28.9K | Sale | 10,155 | $2.85 | Discretionary |
| Jun 26, 2015 | EBIO | $0 | Award | 85,800 | $N/A | Discretionary |